Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his ...

Medically reviewed by Steffini Stalos, DO Bladder cancer occurs when cancerous cells form in the tissues of the bladder, the ...

Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva. Despite promising data and market potential, UroGen's low market cap ...

Two enzyme inhibitors join forces in reducing bladder cancer cell proliferation. n 1996, molecular biologist Kun Ping Lu, a ...

Taking a combination of two drugs including statins could lower cholesterol - and slow the progression of a common cancer, ...

BALTIMORE, Jan. 31, 2025 (GLOBE NEWSWIRE) -- February is National Cancer Prevention Month, and the Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), ...

ImmunityBio will part with 10 employees this quarter. Last fall, it cut 31 employees. The moves come as the biotech works to advance Anktiva in non-small cell lung cancer.

Prostate cancer is one of the most prevalent cancers among men and poses a significant health concern, with its incidence on ...

The subtypes investigated in bladder cancer were CK19 ... but the results of a pilot study are encouraging. Detecting cancer cells in the bloodstream is expected to provide great information ...

TORONTO, ON / ACCESS Newswire / January 27, 2025 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the resear ...

"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...